Semaglutide is a type of medication that has been approved for the treatment of type 2 diabetes. While it is primarily used to control blood sugar levels, it has also been shown to have a significant impact on weight loss. In this blog post, we will explore how semaglutide works to cause weight loss. Align Medical Center in Wellington, Colorado is excited to now offer semaglutide to our patients.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone that is produced in the gut and regulates appetite and glucose metabolism. When GLP-1 levels are high, appetite is suppressed and glucose metabolism is improved. Semaglutide works by mimicking the effects of GLP-1, which helps to control blood sugar levels and reduce appetite.

Suppresses Appetite:

Semaglutide has been shown to reduce the release of hormones that stimulate hunger, such as ghrelin. This can help suppress appetite, which can make it easier for people to stick to a healthy diet and achieve their weight loss goals.

Improves Glucose Metabolism:

Semaglutide has been shown to improve insulin sensitivity and reduce insulin resistance, which can help control blood sugar levels and improve glucose metabolism. This can help prevent the development of serious complications associated with type 2 diabetes.

Increases Energy Expenditure:

Semaglutide has been shown to increase energy expenditure, which can help increase the number of calories burned and contribute to weight loss.

Promotes Fat Loss:

Semaglutide has been shown to promote fat loss, particularly in the abdominal area. This can help improve overall body composition and reduce the risk of developing other health problems.

Northern Colorado Semaglutide at Align Medical Center

Align Medical Center is now offering semaglutide for weight loss, right here in Wellington, Colorado! Learn more about our semaglutide weight loss program and book your consult today.

WARNING: You should not use semaglutide if you are allergic to it, or if you have: multiple endocrine neoplasia type 2; or a personal or family history of medullary thyroid carcinoma. Not for use during pregnancy or when breastfeeding.

Leave a Reply

Your email address will not be published. Required fields are marked *